Masterflex SE (ISIN: DE0005492938) today held its 2026 Annual General Meeting. The shareholders approved the proposal of the Management Board and Supervisory Board and resolved to ...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Masterflex ...

(Reuters) - U.S. lab products provider Avantor Inc will buy Masterflex from privately held Antylia Scientific in a $2.9 billion all-cash deal to beef up its COVID-19 therapy and vaccine manufacturing ...

Portfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems for R&D through high-volume manufacturing Designed for secure fluid ...

Masterflex SE (ETR:MZX) last week reported its latest half-yearly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. It was a ...

Following the acquisition, Avantor will have access to Masterflex’s various bioproduction operations. Avantor announced on Nov. 1, 2021, that it had completed a previously announced acquisition of the ...

Avantor has acquired the Masterflex bioprocessing business and related assets of Antylia Scientific. Avantor has strengthened its offering across all bioproduction platforms with the acquisition of ...

Avantor, Inc. AVTR recently announced a strategic expansion of its Masterflex brand across its fluid handling portfolio. The expansion integrates standard, configurable and engineered-to-order ...

U.S. lab products provider Avantor Inc will buy Masterflex from privately held Antylia Scientific in a $2.9 billion all-cash deal to beef up its COVID-19 therapy and vaccine manufacturing operations.

RADNOR, Pa., Nov. 1, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & ...